We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
280 hedge funds and large institutions have $1.8B invested in ANI Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 110 increasing their positions, 83 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
33% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 83
10.11% more ownership
Funds ownership: 94.26% → 104.37% (+10%)
8% more capital invested
Capital invested by funds: $1.67B → $1.8B (+$127M)
0% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 45
1% less funds holding
Funds holding: 284 → 280 (-4)
51% less call options, than puts
Call options by funds: $15.6M | Put options by funds: $32.1M
Holders
280
Holders Change
-4
Holders Change %
-1.41%
% of All Funds
3.45%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
45
Increased
110
Reduced
83
Closed
45
Calls
$15.6M
Puts
$32.1M
Net Calls
-$16.5M
Net Calls Change
-$2.74M
Top Buyers
| 1 |
GAM
Goldentree Asset Management
New York
|
+$52.1M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$27.1M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$26.1M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$17.6M |
| 5 |
SCM
Sio Capital Management
New York
|
+$13.9M |
Top Sellers
| 1 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
-$17.9M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$16.2M |
| 3 |
ACA
Apis Capital Advisors
New York
|
-$15.5M |
| 4 |
Goldman Sachs
New York
|
-$14.1M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$10.1M |
